HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jeroen Eikenboom Selected Research
Jeroen Eikenboom Research Topics
Disease
23
Hemorrhage
01/2022 - 01/2007
14
von Willebrand Diseases (von Willebrand's Disease)
03/2021 - 07/2011
7
Hemophilia A (Haemophilia)
01/2022 - 08/2004
7
Type 1 von Willebrand Disease
05/2013 - 01/2007
4
Venous Thromboembolism
01/2022 - 02/2015
3
Type 3 von Willebrand Disease
01/2022 - 01/2018
3
Postpartum Hemorrhage
01/2022 - 01/2017
3
Inflammation (Inflammations)
01/2021 - 05/2011
2
Infections
05/2022 - 01/2021
2
Type 2 von Willebrand Disease
01/2022 - 11/2020
2
Pulmonary Embolism
04/2020 - 10/2015
2
Neoplasms (Cancer)
01/2018 - 05/2016
1
COVID-19
05/2022
1
Joint Diseases (Joint Disease)
01/2022
1
Fatigue
06/2021
1
Bernard-Soulier Syndrome (Giant Platelet Syndrome)
06/2020
1
Thrombocytopenia (Thrombopenia)
06/2020
1
Thrombasthenia (Glanzmann Thrombasthenia)
06/2020
1
Thrombosis (Thrombus)
06/2020
1
Heart Failure
06/2020
1
Venous Thrombosis (Deep-Vein Thrombosis)
04/2020
1
Blood Platelet Disorders (Thrombocytopathy)
01/2020
1
Vascular System Injuries
10/2019
1
Atrial Fibrillation
01/2019
1
Cerebral Infarction
01/2019
1
Infarction (Infarctions)
01/2019
1
Intracranial Embolism
01/2019
1
Diabetes Mellitus
01/2018
1
Hypertension (High Blood Pressure)
01/2018
1
Vascular Malformations
01/2018
1
Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
12/2017
1
Stroke (Strokes)
12/2017
1
Leukoencephalopathies
12/2017
1
Wounds and Injuries (Trauma)
04/2016
1
Cardiovascular Diseases (Cardiovascular Disease)
04/2015
1
Postoperative Hemorrhage
03/2014
1
deficiency Von willebrand factor
05/2013
1
Myocardial Infarction
08/2004
Drug/Important Bio-Agent (IBA)
24
von Willebrand Factor
IBA
01/2022 - 01/2007
9
Factor VIII (Coagulation Factor VIII)
IBA
01/2021 - 08/2004
6
Proteins (Proteins, Gene)
FDA Link
11/2020 - 05/2011
5
Deamino Arginine Vasopressin (Desmopressin)
FDA Link
Generic
01/2022 - 04/2008
5
Biomarkers (Surrogate Marker)
IBA
03/2013 - 01/2007
4
Hemostatics (Antihemorrhagics)
IBA
05/2022 - 10/2018
4
Anticoagulants
IBA
06/2020 - 02/2015
3
Antigens
IBA
01/2021 - 01/2018
2
Blood Group Antigens (Blood Groups)
IBA
01/2021 - 01/2018
2
Fibrinogen (Factor I)
FDA Link
10/2018 - 03/2014
1
Antithrombins
IBA
01/2022
1
4-amino-4'-hydroxylaminodiphenylsulfone (HADS)
IBA
06/2021
1
Steroids
IBA
01/2021
1
Hormones (Hormone)
IBA
01/2021
1
Small Interfering RNA (siRNA)
IBA
11/2020
1
Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)
IBA
07/2020
1
Adenosine Diphosphate (ADP)
IBA
06/2020
1
Thromboxane A2 (A2, Thromboxane)
IBA
06/2020
1
apixaban
IBA
04/2020
1
Vitamin K
FDA Link
04/2020
1
Tin
IBA
01/2020
1
Quinacrine (Mepacrine)
IBA
01/2020
1
Blood Coagulation Factors (Coagulation Factor)
IBA
01/2019
1
Gold
IBA
01/2019
1
Hemoglobins (Hemoglobin)
IBA
10/2018
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2018
1
Retinaldehyde (Retinal)
IBA
12/2017
1
Tranexamic Acid (AMCA)
FDA Link
01/2017
1
Thromboplastin (Tissue Factor)
IBA
10/2015
1
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
04/2015
1
Cysteine (L-Cysteine)
FDA Link
06/2012
1
Disulfides
IBA
06/2012
1
Biological Products
IBA
04/2008
Therapy/Procedure
5
Therapeutics
01/2022 - 05/2016
2
Cardiopulmonary Bypass (Heart-Lung Bypass)
05/2022 - 04/2016
1
Thrombolytic Therapy
01/2022
1
Heart-Assist Devices
06/2020
1
Catheters
01/2019
1
Catheter Ablation
01/2019
1
Blood Transfusion (Blood Transfusions)
10/2018
1
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2015
1
Aftercare (After-Treatment)
02/2015